Global Genitourinary Partnering 2010-2020: Deal trends, players and financials

Global Genitourinary Partnering 2010-2020: Deal trends, players and financials

Global Genitourinary Partnering 2010 to 2020 provides the full collection of Genitourinary disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.

Trends in Genitourinary partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Genitourinary partnering agreement structure
Genitourinary partnering contract documents
Top Genitourinary deals by value
Most active Genitourinary dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Genitourinary disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Genitourinary deals.

The report presents financial deal terms values for Genitourinary deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Genitourinary dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Genitourinary dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Genitourinary deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Genitourinary dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Genitourinary deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Genitourinary partnering deals by specific Genitourinary target announced since 2010. The chapter is organized by specific Genitourinary therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Genitourinary partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Genitourinary partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Genitourinary technologies and products.

Report scope

Global Genitourinary Partnering 2010 to 2020 is intended to provide the reader with an in-depth understanding and access to Genitourinary trends and structure of deals entered into by leading companies worldwide.

Global Genitourinary Partnering 2010 to 2020 includes:

Trends in Genitourinary dealmaking in the biopharma industry since 2010
Analysis of Genitourinary deal structure
Access to headline, upfront, milestone and royalty data
Access to hundreds of Genitourinary deal contract documents
Comprehensive access to over 530 Genitourinary deal records
The leading Genitourinary deals by value since 2010
Most active Genitourinary dealmakers since 2010

The report includes deals for the following indications: Discharge, Frequency, Incontinence, Itching, Nocturia, Urgency, Acute kidney injury, Amyloidosis, Chronic kidney disease (CKD), Cystitis, Diabetic nephropathy, Dialysis, Hemolytic-uremic syndrome (HUS), Kidney stones, Nephrotic syndrom, Overactive bladder, Peyronie's disease, Polycystic kidney disease, Prostate diseases, Prostatitis, Prostate enlargement, Renal failure, Renal infections, Nephritis, Glomerulonephritis, Pyelonephritis, Vesicoureteral reflux, Urinary tract infection (UTI), plus other genitourinary indications.

In Global Genitourinary Partnering 2010 to 2020, available deals and contracts are listed by:

Headline value
Upfront payment value
Royalty rate value
Stage of development at signing
Deal component type
Technology type
Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Genitourinary Partnering 2010 to 2020 report provides comprehensive access to available deals and contract documents for over 530 Genitourinary deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise Genitourinary rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How are sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?


  • Executive Summary
  • Introduction
  • Trends in Genitourinary dealmaking
    • Introduction
    • Genitourinary partnering over the years
    • Genitourinary partnering by deal type
    • Genitourinary partnering by industry sector
    • Genitourinary partnering by stage of development
    • Genitourinary partnering by technology type
    • Genitourinary partnering by therapeutic indication
  • Financial deal terms for Genitourinary partnering
    • Introduction
    • Disclosed financials terms for Genitourinary partnering
    • Genitourinary partnering headline values
      • Table Genitourinary deals with a headline value
    • Genitourinary deal upfront payments
      • Table Genitourinary deals with upfront payment values
    • Genitourinary deal milestone payments
      • Table Genitourinary deals with milestone payment
    • Genitourinary royalty rates
      • Table Genitourinary deals with royalty rates
  • Leading Genitourinary deals and dealmakers
    • Introduction
    • Most active in Genitourinary partnering
    • List of most active dealmakers in Genitourinary
      • Astellas Pharma
      • Fresenius Medical Care
      • Amgen
      • AstraZeneca
      • Baxter International
      • DaVita
      • Novartis
      • Nxstage Medical
      • Urovant Sciences
      • Atara Biotherapeutics
      • Nephrogenex
      • Swedish Orphan Biovitrum
      • Vifor Pharma
      • Alnylam Pharmaceuticals
      • Astute Medical
      • Boehringer Ingelheim
      • Boston Scientific
      • Evotec
      • Mayo Clinic
      • MediGene
      • National Institutes of Health
      • Nephros
      • Pfizer
      • RenalytixAI
      • Rockwell Medical
    • Top Genitourinary deals by value
      • Table Top Genitourinary deals by value since 2010
  • Genitourinary contract document directory
    • Introduction
    • Genitourinary partnering deals where contract document available
  • Genitourinary dealmaking by therapeutic target
    • Introduction
    • Deals by Genitourinary therapeutic target
      • Genitourinary
      • Acute kidney injury
      • Amyloidosis
      • Chronic kidney disease (CKD)
      • Stage 3
      • Stage 4
      • Stage 5
      • Cystitis
      • Diabetic nephropathy
      • Dialysis
      • Symptoms
      • Discharge
      • Frequency
      • Incontinence
      • Nocturia
      • Urgency
      • Hemolytic-uremic syndrome (HUS)
      • Kidney stones
      • Nephrotic syndrome
      • Overactive bladder
      • Peyronie's disease
      • Polycystic kidney disease
      • Prostate diseases
      • Prostate enlargement
      • Renal failure
      • Renal infections
      • Glomerulonephritis
      • Nephritis
      • Urinary tract infection (UTI)
      • Vesicoureteral reflux
  • Appendices
    • Directory of Genitourinary deals by company A-Z 2010 to 2020
      • 3SBio
      • 4D Science
      • A1M Pharma
      • AbbeyMoor Medical
      • Abbott Laboratories
      • Abbvie
      • Acerus
      • Aceso Life Science
      • Aceto Corporation
      • ACIST Medical Systems
      • Acon Labs
      • Action Pharma
      • Acurx Pharmaceuticals
      • AEterna Zentaris
      • Aethlon Medical
      • Aetna
      • Affymax
      • AirStrip Technologies
      • Akebia Therapeutics
      • AKESOgen
      • Alavita Pharmaceuticals
      • AlCana Technologies
      • Alere Health
      • Alivio Therapeutics
      • Allegis Holdings
      • Allena Pharmaceuticals
      • Allergan
      • Allium Medical Solutions
      • Alnylam Pharmaceuticals
      • Altavant Sciences
      • Althea Technologies
      • AltheRx
      • AM-Pharma
      • Amag Pharmaceuticals
      • Ambu
      • American Diabetes Association
      • American Lung Association
      • American Medical Systems
      • American Urological Association
      • Amerigen Pharmaceuticals
      • Amerinet
      • Amgen
      • AmorChem
      • Angelini Pharma
      • Angion Biomedica
      • Angiotech Pharmaceuticals
      • ANI Pharmaceuticals
      • Antares Pharma
      • Anthem Bluecross
      • Anthera Pharmaceuticals
      • AorTech
      • Apellis Pharmaceuticals
      • Apocell
      • Apollo Hospitals Group
      • Applied Medical
      • Aquinox Pharmaceuticals
      • Archimedes Pharma
      • Arch Biopartners
      • Ardelyx
      • Arena Pharmaceuticals
      • Argon Medical Devices
      • Argutus Medical
      • Arizona State University
      • Arkray USA
      • Arrevus
      • Arriani Pharmaceuticals
      • Asahi Kasei
      • Ascend Clinical
      • Ascend Therapeutics
      • ASD Speciality Healthcare
      • ASKA Pharmaceuticals
      • Assembly Biosciences
      • Astellas Pharma
      • Astellas Pharma US
      • AstraZeneca
      • Astute Medical
      • Atara Biotherapeutics
      • Atlantic Dialysis Management Services
      • Auven Therapeutics
      • Auxilium Pharmaceuticals
      • Avanti Specialty Pharmacy Management
      • AWAK Technologies
      • Axonics Modulation Technologies
      • Ayogo Health
      • Aytu BioScience
      • Aziyo Biologics
      • Bausch & Lomb
      • Baxter International
      • Baylor Health Care System
      • Beckman Coulter
      • Beijing King Health
      • Beijing Leadman Biochemistry
      • Bellco Health Care
      • Bellus Health
      • Beth Israel Deaconess Medical Center
      • BIOASTER
      • BioCad Holding
      • Biocon
      • BioDerm
      • BioLink Life Sciences
      • Biomedical Advanced Research and Development Authority
      • Biomerica
      • BioMerieux
      • BioPorto
      • BioSerenity
      • Biostar Pharmaceuticals
      • BioVectra
      • BK Medical
      • Blackstone
      • Bladder Health Network
      • Blue Cross Blue Shield Association
      • Boehringer Ingelheim
      • Boston Scientific
      • Bridge Medicines
      • Brigham and Women's Hospital
      • B Braun
      • Caelum Biosciences
      • Caldera Pharmaceuticals
      • Calliditas Therapeutics
      • CamelBak
      • Canadian Urological Association
      • Cancer Genetics
      • Cara Therapeutics
      • CARB-X
      • Cardio Renal Society of America
      • CareDx
      • Casper Pharma
      • CB2 Therapeutics
      • Celgene
      • CELLINK
      • Celtic Biotech
      • Cenas
      • Champion Manufacturing
      • ChemoCentryx
      • Children's Mercy Hospital
      • China Medical System
      • Chinese National Institute of Hospital Administration
      • Chinook Therapeutics
      • Chong Kun Dang
      • Cigna Healthcare
      • CJ Corp
      • Cleveland Clinic
      • Clinipace Worldwide
      • CMX Research
      • Codan Triplus
      • Codexis
      • Cogentix Medical
      • Collaborative Study Group
      • Coloplast
      • Columbia University
      • Commercialisation Australia
      • Companhia Portuguesa Higiene
      • Concert Pharmaceuticals
      • Control Flo Medical
      • Cook Biotech
      • Cook Medical
      • Cooper Surgical
      • Cordis
      • Corino Therapeutics
      • Covance
      • Cricket Health
      • Critical Path Institute (C-Path)
      • CrossBay Medical
      • Cryolife
      • Cubist Pharmaceuticals
      • Cumberland Pharmaceuticals
      • CureBeta
      • CytoSorbents
      • C R Bard
      • Daewoong Pharmaceutical
      • Dainippon Sumitomo Pharma
      • Dako
      • Dalton Pharma Services
      • Danish Innovation Fund
      • DaVita
      • DaVita HealthCare Partners
      • Daxor
      • Debiopharm
      • Debiotech
      • Defense Advanced Research Projects Agency
      • Degania Silicone
      • Diaverum
      • Dicerna Pharmaceuticals
      • Dignify Therapeutics
      • DILIsym Services
      • Dimerix Biosciences
      • Dirinco
      • DiscoveryBioMed
      • Distal Access
      • Diurnal
      • Dr. Reddy's Laboratories
      • Drais Pharmaceuticals
      • DSG Partners
      • DSM Biomedical
      • Duchesnay
      • Ecole Polytechnique Federale de Lausanne
      • ECR Pharmaceuticals
      • EDAP TMS
      • EirGen Pharma
      • EKF Diagnostics (Germany)
      • Elexopharm
      • Eli Lilly
      • Eloquest Healthcare
      • EMD Serono
      • EndoStim
      • Endo International
      • Enteris Biopharma
      • Enzyvant Science
      • Epigen Biosciences
      • Epitech
      • Erasmus University Medical Center
      • Eton Pharmaceuticals
      • EuroCept
      • Euromedic
      • European Commission
      • Everest Medicines
      • Eversana
      • Evestra
      • Evgen Pharma
      • Evolva
      • Evotec
      • Exosome Diagnostics
      • Expanscience
      • Fedora Pharmaceuticals
      • Ferring Pharmaceuticals
      • Fibrogen
      • Fimbrion Therapeutics
      • FirstString Research
      • Fleming Pharmaceuticals
      • Forendo Pharma
      • Fosun Pharmaceutical
      • Fougera Pharmaceuticals
      • Foundation for International Urogynecological Assistance
      • Fred Hutchinson Cancer Research Center
      • French Investment Fund
      • Frenova Renal Research
      • Fresenius Medical Care
      • FSC Laboratories
      • Galenica
      • Gambro
      • GC Rise
      • Gebro Pharma
      • Gedeon Richter
      • Geisinger Medical Center
      • GeneNews
      • Genewiz
      • Genexo
      • Genzyme
      • George Washington University
      • German Federal State Baden-Wurttemberg
      • GE Healthcare
      • Gilead Sciences
      • Girlow USA
      • GlaxoSmithKline
      • Goldfinch Bio
      • Government of Canada
      • Great Bay Bio
      • Guangzhou Boji Medical Biotechnological
      • GVK Biosciences
      • Haemonetics
      • Hainan Sihuan Pharmaceutical
      • Hancock Jaffe Laboratories
      • Hangzhou Zhongmei Huadong Pharmaceutical
      • Harbor Island Development
      • Harland Medical Systems
      • Harvard Stem Cell Institute
      • Harvard University
      • Health-Chem Diagnostics
      • HealthTrust Purchasing Group
      • Healthy.io
      • Hegln
      • Helix BioPharma
      • HemoCleanse
      • Heritage California ACO
      • Hisamitsu Pharmaceutical
      • Hitachi Medical Systems Europe
      • Hologic
      • Horizon Therapeutics
      • Humana
      • Hycor Biomedical
      • Hydra Biosciences
      • HydroCision
      • Hyperion Therapeutics
      • Ibidi
      • IC-MedTech
      • Icahn School of Medicine at Mount Sinai
      • Ideal Concept Group
      • Ideal Medical Solutions
      • Idera Pharmaceuticals
      • IDIBELL
      • IGAN Biosciences
      • Ikaria
      • ILJIN Life Science
      • Impax Laboratories
      • ImpediMed
      • Imprimis Pharmaceuticals
      • Innovation Network Corporation
      • Innovative Diagnostic Laboratory
      • Innovus Pharmaceuticals
      • Institut National Recherche Agronomique
      • Instrumentation Laboratory
      • Intellikine
      • Intercept Pharmaceuticals
      • Interface Biologics
      • Interpace Diagnostics Group
      • Invacare
      • InVasc Therapeutics
      • Inventia Healthcare
      • Invitae
      • InVivo
      • Ionis Pharmaceuticals
      • Ion Channel Innovations
      • IRIS International
      • Isotechnika Pharma
      • Itochu
      • Ivax Diagnostics
      • Janssen Pharmaceuticals
      • Janssen Research & Development
      • Japan Tobacco
      • Johnson & Johnson
      • Johns Hopkins University
      • Joslin Diabetes Center
      • JS Bio Pharm
      • Juventas Therapeutics
      • Juvise Pharmaceuticals
      • KAI Pharmaceuticals
      • Kane Biotech
      • Karolinska Institute
      • Karo Bio
      • KBI BioPharma
      • Keryx Biopharmaceuticals
      • Kissei Pharmaceutical
      • Kleiner Perkins Caufield & Byers
      • Kova International
      • Kwang Dong Pharmaceutical
      • Kyorin Pharmaceutical
      • Kyowa Hakko Kirin
      • Kyowa Hakko Kogyo
      • L&F Research
      • Laboratorios Inibsa
      • Laboratorios Q Pharma
      • Laboratorios SALVAT
      • Laborie Medical Technologies
      • Laurel Crown Partners
      • Lavasta Pharma
      • La Jolla Pharmaceutical
      • Leiden University
      • LeMaitre Vascular
      • Life-Tech
      • Locus Biosciences
      • Lumenis
      • Lupus Foundation of America (LFA)
      • Luqa Pharmaceuticals
      • Maisonneuve-Rosemont Hospital (HMR)
      • Mallinckrodt Pharmaceuticals
      • Mannin Research
      • Mariel Therapeutics
      • Maruishi Pharmaceutical
      • Mar Cor Purification
      • Massachusetts General Hospital
      • Massachusetts Life Sciences Center
      • Mayo Clinic
      • MD Anderson Cancer Center
      • Medac
      • MedCom
      • MediBeacon
      • Medical Components
      • Medical Measurement Systems
      • Medical Research Council
      • Medica Avante
      • Medifocus
      • MediGene
      • MedImmune
      • Medinova
      • Medipal Holdings
      • Medison Pharma
      • Medisystems
      • Meditrina Pharmaceuticals
      • Medline Industries
      • Medpace
      • Medtronic
      • Meiji Seika
      • Meizler
      • Melinta Therapeutics
      • Memorial Sloan Kettering Cancer Center
      • Menarini
      • Merck Sharpe & Dohme
      • Merlin Technologies
      • Merus
      • Merus Labs International
      • Merz
      • Metabolon
      • Metamark Genetics
      • Methuselah Foundation
      • Metro Medical Supply
      • MicrobeDx
      • Microsulis Medical
      • Mimetas
      • Ministry of Health (China)
      • Ministry of Health (Saudi Arabia)
      • Minnesota Medical
      • Mironid
      • Mission Pharmacal
      • Mitobridge
      • Mitsubishi Pharma
      • Mitsubishi Tanabe Pharma
      • Moderna Therapeutics
      • Molecular Targeting Technologies
      • Mount Sinai Health System
      • MRM Proteomics
      • MultiPlan
      • Murdoch Childrens Research Institute
      • Mylan Laboratories
      • Myovant Sciences
      • NacuGen Therapeutics
      • NanoBio
      • NanoVibronix
      • Nashville Biosciences
      • National Centre for the Replacement, Refinement and Reduction of Animals in Research
      • National Heart, Lung and Blood Institute
      • National Institutes of Health
      • National Institute of Allergy and Infectious Diseases
      • National Institute of Child Health and Human Development
      • National Institute of Diabetes and Digestive and Kidney Diseases
      • National Kidney Foundation
      • National Kidney Registry
      • National University of Singapore
      • NCPC GeneTech
      • Neokidney
      • NephCure Kidney International
      • Nephrogenex
      • Nephron Dx
      • Nephros
      • Neptune Technologies & Bioressources
      • Nestle Health Science
      • NeuralStem
      • NeuroMetrix
      • New York University School of Medicine
      • NextPharma
      • Nikkiso
      • Nile Therapeutics
      • Nippon Shinyaku
      • NMI Natural and Medical Sciences Institute
      • Nordic Medcom
      • Norgenix Pharmaceuticals
      • Norgine
      • Nosopharm
      • NovaMed Pharmaceuticals
      • Novartis
      • Novation
      • Noventure
      • Novo Nordisk
      • NuChem Therapeutics
      • Nxstage Medical
      • Nx Stage Medical
      • Nymox Pharmaceutical
      • NYU Langone Medical Center
      • Oceana Therapeutics
      • Olympus
      • Omron
      • OM Pharma
      • Onegevity
      • One Rock Capital Partners
      • Only for Children Pharmaceuticals
      • Ono Pharmaceutical
      • OpGen
      • OPKO Health
      • Organovo
      • Orphan Therapeutics
      • Ortho-Clinical Diagnostics
      • Osprey Medical
      • Ostial Solutions
      • Otsuka
      • Outpost Medicine
      • Oxford Immunotec
      • Palette Life Sciences
      • Pall Corporation
      • Panion & BF Biotech
      • Pansend
      • Par Pharmaceutical
      • PathCentral
      • Patheon
      • Pelham Plastics
      • Perlara
      • Perugia University
      • Pervasis Therapeutics
      • Pfizer
      • Pfizer Animal Health
      • Phadia
      • Pharmacological research Institute Mario Negri
      • Pharmalink AB
      • Pharmalink Consulting
      • PharmaNet Development Group
      • PharmaSwiss
      • PharmLogic
      • Pharmstandard
      • Pharmsynthez
      • Pharsight
      • Phase One Medical
      • Pherecydes Pharma
      • Phosphate Therapeutics
      • Pierre Fabre
      • Piramal
      • PKD Foundation
      • PLC Systems
      • PlugMed
      • POA Pharma Scandinavia
      • Poiesis Medical
      • PPD
      • Prasco Laboratories
      • Precision Image Analysis
      • Premier Healthcare Alliance
      • Premier Inc
      • Premier Purchasing Partners
      • Prismic Pharmaceuticals
      • Procept BioRobotics
      • Promega
      • Promepla
      • Promethera Biosciences
      • Prometic Life Sciences
      • PROOF Centre of Excellence for Commercialization and Research
      • Proteomics International
      • Protiva Biotherapeutics
      • Protox Therapeutics
      • Provesica
      • Proximum
      • Purdue Pharma
      • PX Therapeutics
      • Pyramed
      • Quanta Dialysis Technologies
      • Quark Pharmaceuticals
      • Quebec Urological Association Foundation
      • Quimica Europea
      • Q BioMed
      • Rambam Medical Center
      • RaNA Therapeutics
      • Raptor Pharmaceutical
      • REACH Kidney Care
      • Reata Pharmaceuticals
      • Rebiotix
      • Recordati
      • Recordati Espana
      • ReCor Medical
      • Regenerex
      • Regional Health Care Group
      • Regulus Therapeutics
      • Relief Therapeutics
      • RenalSense
      • RenalytixAI
      • Renal Advantage
      • Renovar
      • RENX AI Labs
      • Resverlogix
      • Retrophin
      • Reveal Pharmaceuticals
      • Rex Medical
      • RFSU
      • Richard Wolf Medical Instruments
      • Rising Pharmaceuticals
      • Roche
      • Rockwell Medical
      • Roivant Sciences
      • ROi (Resource Optimization & Innovation)
      • Royal Children's Hospital
      • Saniona
      • Sanofi
      • Sanwa Kagaku Kenkyusho
      • Sartorius Stedim Biotech
      • Satellite Healthcare
      • Scanwell Health
      • Schnitzler Cardiovascular Consultants
      • SciClone Pharmaceuticals
      • Scohia Pharma
      • Searchlight Pharma
      • Seattle Childrens Research Institute
      • Selecta Biosciences
      • Selexis
      • Serenity Pharmaceuticals
      • Serodus
      • Shanghai Institute of Materia Medica
      • Shanghai Yangpu Antu Hospital
      • Shenzhen Hepalink Pharmaceutical
      • Shenzhen University
      • Shiel Medical Laboratory
      • Shionogi
      • Shire Laboratories
      • Shire Pharmaceuticals
      • Siemens
      • Siemens Healthcare Diagnostics
      • Siemens Healthineers
      • Silence Therapeutics
      • Simavita
      • Sinovant Sciences
      • SK Chemicals
      • SLA Pharma
      • Solana Therapeutics
      • SOM Biotech
      • Sonacare Medical
      • South Coast Specialty Compounding
      • SPCare
      • Specialty Renal Products
      • Spectra Laboratories
      • Sphingotec
      • Spindial
      • SRS Medical
      • Stanford University
      • Starr Foundation
      • STATegics
      • Stellar Pharmaceuticals
      • Stem Cell Network
      • StoneCreek Capital
      • Stryker
      • Sumitovant Biopharma
      • Summa Health System
      • Sunovion Pharmaceuticals
      • Sun Pharmaceutical
      • Swansea University
      • Swedish Orphan Biovitrum
      • Swixx Biopharma
      • Symic Biomedical
      • Syneron
      • Sysmex
      • Sysmex America
      • Tacurion
      • Takeda Pharmaceutical
      • TARIS Biomedical
      • Teijin
      • TekMed
      • Tekmira Pharmaceuticals
      • Teleflex
      • Telix Pharmaceuticals
      • Tengion
      • Tetra Bio-Pharma
      • Teva Pharmaceutical Industries
      • Theradial
      • TheraVida
      • Thermedx
      • The Medical Affairs Company
      • The Medicines Company
      • Thorne Research
      • Tissue Genesis
      • Toray
      • ToSense
      • Trace Analytics
      • Tufts Medical Center
      • Tulane University
      • TwoXAR
      • Ucyclyd Pharma
      • Unilife
      • UniQuest
      • United Medical Systems (UMS)
      • University Medical Center Groningen
      • University of Arkansas
      • University of Bonn
      • University of Bristol
      • University of British Columbia
      • University of California, San Diego
      • University of California Los Angeles
      • University of Cambridge
      • University of Florida
      • University of Glasgow
      • University of Houston
      • University of Louisville
      • University of Miami
      • University of Michigan
      • University of Notre of Dame
      • University of Pennsylvania
      • University of Rhode Island
      • University of Rochester
      • University of Sheffield
      • University of South Carolina
      • University of South Carolina Research Foundation
      • University of Texas
      • University of Texas at El Paso
      • University of Tubingen
      • University of Utah
      • University of Veterinary Medicine of Hannover
      • University of Wuerzburg
      • Upsher-Smith
      • Urigen
      • Urodynamix Technologies
      • UroGen Pharma
      • UroGPO
      • Urologix
      • UROsphere
      • Urotronic
      • Urovant Sciences
      • USMD Holdings
      • Valeant Pharmaceuticals
      • Validus Pharmaceuticals
      • Vanderbilt University
      • Variant Pharmaceuticals
      • Varian Medical Systems
      • VenatoRx
      • Verity Pharmaceuticals
      • Vifor-Fresenius Medical Care Renal Pharma Ltd
      • Vifor Pharma
      • Vinnova
      • Viracor-IBT
      • Viscofan BioEngineering
      • VisiQuate
      • Vivax Pharmaceutical
      • ViveBio
      • Viveca Biomed
      • Vivere Health
      • Vivione Biosciences
      • Vizient
      • VolitionRX
      • Warner Chilcott
      • Watson Pharmaceuticals
      • Weill Cornell Medical College
      • Womens Choice Pharmaceuticals
      • Wood Creek Capital
      • Wuxi Apptec Laboratory Services
      • Wyeth
      • Xanodyne Pharmaceuticals
      • Xenon Pharmaceuticals
      • Xention
      • Xijing Hospital
      • Xisle Pharma Ventures Trust
      • Xortx Therapeutics
      • Yale University
      • Yung Shin Pharm
      • Zambon France
      • Zealand Pharma
      • Zenalux Biomedical
      • Zenyaku Kogyo
      • Zydus Cadila
      • ZyVersa Therapeutics
    • Directory of Genitourinary deals by deal type 2010 to 2020
      • Asset purchase
      • Bigpharma outlicensing
      • Co-development
      • Collaborative R&D
      • Co-market
      • Contract service
      • Co-promotion
      • CRADA
      • Cross-licensing
      • Development
      • Distribution
      • Equity purchase
      • Evaluation
      • Grant
      • Joint venture
      • Licensing
      • Litigation
      • Manufacturing
      • Manufacturing - OEM
      • Marketing
      • Option
      • Promotion
      • Research
      • Royalty financing
      • Settlement
      • Spin out
      • Sub-license
      • Supply
      • Technology transfer
      • Termination
    • Directory of Genitourinary deals by stage of development 2010 to 2020
      • Discovery
      • Preclinical
      • Phase I
      • Phase II
      • Phase III
      • Regulatory
      • Marketed
      • Formulation
    • Directory of Genitourinary deals by technology type 2010 to 2020
      • Analysis
      • Animal models
      • Antibiotics
      • Cephalosporin
      • Penicillin
      • Monoclonal antibodies
      • AI/Artificial intelligence
      • Assays
      • Bioinformatics
      • Biological compounds
      • Biomarkers
      • Biomaterials
      • Biosimilars/Bio-betters
      • Blood products
      • Cell culture
      • Clinical testing
      • CRISPR
      • Devices
      • Surgical devices
      • Surgical robotics
      • Wearable devices
      • Diagnostics
      • Companion
      • Imaging
      • CT
      • Endoscope
      • MRI
      • Ultrasound
      • In vitro diagnostics
      • Molecular diagnostics
      • Prognostics
      • Discovery tools
      • High throughput screening (HTS)
      • DNA probes
      • Drug delivery
      • Implantable
      • Oral delivery
      • Delayed release
      • Infusion
      • Injectable
      • Pro-drug
      • Targeted
      • Topical
      • Transdermal
      • Nasal
      • Urogenital
      • Enabling technology
      • Equipment
      • Facilities
      • Gene therapy
      • Genomics
      • Implant
      • Industrial chemicals
      • In vitro models
      • Microbiome
      • Natural product
      • Oligonucleotide
      • Peptides
      • Personalised medicine
      • Precision medicine
      • Processes
      • Proteomics
      • Radio/Chemo-therapy
      • Recombinant DNA
      • Regenerative medicine
      • Cell therapy
      • Organ regeneration
      • Stem cells
      • Tissue regeneration
      • Research services
      • Research supplies
      • RNA therapeutics
      • Screening
      • Small molecules
      • Software tools
      • Digital therapeutics
      • Toxicity
      • Vaccines
      • Bacteriophage (phage)
    • Further reading on dealmaking
    • Deal type definitions
  • About Wildwood Ventures
    • Current Partnering
    • Current Agreements
    • Recent report titles from CurrentPartnering

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook